News & Blog

Read all the latest updates on our charity, clinical advances in melanoma treatment, patient stories, fundraising and events.

For Press Releases & Media

Craig’s Story

During 2021, Craig was diagnosed with stage 2 melanoma which unfortunately later progressed to stage 4 during 2022. He started immunotherapy (ipilimumab and nivolumab) during June 2022 and unfortunately, he experienced side effects leading to sepsis and hepatitis. Once this was managed, he found out in September 2022 that he was No Evidence of Disease (NED). He now receives scans every 3 months and wants to share his story to provide hope to others.

Patient Stories

Read more

NICE’s draft guidance to currently NOT recommend lifileucel (TILs treatment) for previously treated unresectable or metastatic melanoma

The NICE Technology Appraisal Committee has published the draft guidance to currently NOT recommend lifileucel (TILs treatment) for previously treated unresectable or metastatic melanoma. This is not NICE's final guidance and the recommendations may change after the consultation which closes on 5pm on 22 January 2026.

Charity News, Clinical Advances

Read more